Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Researchers at Novartis present new insulin-like growth factor 1 receptor antagonists

Jan. 18, 2012

Full results published of phase III breast cancer study CLEOPATRA

Jan. 18, 2012

Phase III study of elacytarabine delayed by manufacturing issues

Jan. 17, 2012

Novel insulin-like growth factor 1 receptor antagonists patented by Novartis

Jan. 17, 2012

Novel dual specificity protein kinase TTK inhibitors reported

Jan. 16, 2012

Polaris begins dosing in ADI-PEG 20/docetaxel combination study

Jan. 13, 2012

NovoMedix patents new eIF4E inhibitors for cancer

Jan. 13, 2012

Evotec achieves milestone for oncology product from Boehringer Ingelheim

Jan. 13, 2012

Novartis discovers new pan-Trk kinase inhibitor

Jan. 13, 2012

Kadmon acquires anticancer candidate from Concordia Pharmaceuticals

Jan. 12, 2012

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...